The capsule, developed by Krakow-based startup AILIS, is the only one of its kind in the world and offers a non-invasive, radiation-free alternative to traditional methods like mammography and ultrasound.
“If the project successfully passes further stages of research, Poland will undoubtedly become a leader in early breast cancer detection using artificial intelligence,” said Dr. Katarzyna Chrobak-Kasprzyk from the Kraków Oncology Institute.
The device uses Parametric Dynamic Imaging to capture 21,000 measurements of breast tissue in just four minutes.
It identifies cancerous changes by detecting abnormalities in blood vessel structures before a tumor is visible.
This method is particularly useful for women under 50, who often have dense breast tissue that makes tumors harder to detect with standard imaging techniques.
“We are especially targeting young women because 27% of newly detected cancers affect those under 50,” Dr. Chrobak-Kasprzyk said, adding that “initial results are very promising.”
The device has already examined 1,500 healthy women and is now being tested on 300 patients with suspected cancerous changes.
The current clinical evaluation phase will last another year, with hopes of bringing the system to market soon.
